Efficacy of lorlatinib in patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC) and ALK kinase domain mutations Meeting Abstract
| Authors: | Shaw, A. T.; Martini, J. F.; Besse, B.; Bauer, T. M.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Clancy, J. S.; Li, S.; Thurm, H.; Satouchi, M.; Camidge, D. R.; Kao, S.; Chiari, R.; Gadgeel, S.; Felip, E.; Solomon, B. J. |
| Abstract Title: | Efficacy of lorlatinib in patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC) and ALK kinase domain mutations |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900041 |
| DOI: | 10.1158/1538-7445.Am2018-ct044 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT044 -- Source: Wos |
